Home>Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway
Luteolin overcomes acquired resistance to osimertinib in non-small cell lung cancer cells by targeting the HGF-MET-Akt pathway
- Impact factors: 5.3
- Publication: American Journal of Cancer Research
- Author:Guodong Huang, Xinning Liu, Ting Jiang, Yufeng Cao, Mingyu Sang, Xiaomeng Song, Baochen Zhou, Honglin Qu, Houhao Cai, Daijun Xing, Yuecheng Mao, Gaoyang Lin, Xiantao Liu, Xin Zheng
- DOI citation-doi:PMID:37818074
- Date:2023-09-15